Journal of the American Medical Association

November 13, 2023

Most can lower blood pressure by reducing salt, even those on BP drugs: study

New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake.

By Bill Snyder
Wesley Self, MD, MPH
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.

By Nancy Humphrey
May 12, 2021

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

By Craig Boerner
November 9, 2020

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

By Bill Snyder
September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

By Nancy Humphrey
February 27, 2020

Study finds certain genetic test not useful in predicting heart disease risk

A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk.

By Matt Batcheldor
August 20, 2019

Quitting smoking associated with lower risk of cardiovascular disease

A new Vanderbilt study documents the great incentive for current smokers to quit.
By Matt Batcheldor
February 15, 2018

Sepsis trial ranked No. 1 on critical care website

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
By Leigh MacMillan
March 21, 2017

Study shows active surveillance preserves quality of life for prostate cancer patients

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
By Craig Boerner
June 14, 2016

Study shows opioids increase risk of death when compared to other pain treatments

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
By Craig Boerner
October 22, 2015

Guillamondegui: One standard needed to track concussions

Data in sports concussion studies will continue to be disputed as long as the injuries are diagnosed by differing standards instead of universal guidelines, a Vanderbilt investigator concludes in a recent review.
By Tom Wilemon
June 25, 2015

Vanderbilt study on spinal cord injuries will guide interventions

Traumatic spinal cord injuries are increasing with the population, and incidence is higher in older patients, according to a Vanderbilt study that was published in the Journal of the American Medical Association.
By Matt Batcheldor
February 12, 2015

Report calls for new chronic fatigue guidelines

An Institute of Medicine committee chaired by Vanderbilt University’s Ellen Wright Clayton, M.D., J.D., on Tuesday called for a new name and new diagnostic criteria for what is familiarly known as chronic fatigue syndrome.
By Bill Snyder
1 2